Global HIV Diagnostics Market By Types (HIV-1, HIV-2); By Sample (Urine, Blood, Saliva); By Product (Consumables – Assay, Kits and Reagents, Software and Instruments); By Test Type (Antibody tests, Antigen/ antibody tests, Nucleic Acid Tests (NAT), CD4 cell count testing, ELISA Test); By Distribution Channel (Online, Offline); By End Users (Diagnostic Laboratories, Hospitals, Blood Banks, Homecare Settings, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global HIV diagnostics market was valued at US$ 3.88 Bn in 2021, growing at an estimated CAGR of 10.6% over the forecast period. Acquired Immunodeficiency Syndrome (AIDS) is one of those disease of which no complete cure has been found by the mankind. Irrespective of massive technological advancements seen by the medical science, we have failed to battle AIDS or the virus that causes this dreadful disease. Human Immunodeficiency Virus (HIV) is the main cause behind this disease. While this virus can be transmitted through several ways like unprotected sex and blood transmission, we have been successful in inventing tools that help in preventing its spread. Use of condom has majorly proven helpful in curbing the spread of the virus. On the other hand, if detected early, the medical fraternity can save the unborn child from getting infecting. Though the root cause of this virus or origin still remains matter of debate, newer ways of diagnosis are being sought. As diagnosis is truly the first step towards a successful treatment, the global HIV diagnostics market is aggressively growing.
The coronavirus pandemic proved fruitful for the growth of the global HIV diagnostics market. People with co-morbidities or already battling HIV were under threat of being attacked by the dreadful virus. This was because, the HIV positive patients have a weakened immunity. Extra care of such patients was taken during the pandemic.
Type Outlook
On the basis of types, the global HIV diagnostics market has been divided into HIV-1, and HIV-2. While both these types of viruses are same in terms of basic arrangement of genes, ways of transmission, intracellular replication of pathways along with clinical consequences as both these viruses results in AIDS. Though chances of one getting infected by HIV-1. On the other hand, HIV-2 has lower rate of transmissibility along with declined chances of resulting into AIDS.
Global HIV Diagnostics Market Revenue & Forecast, (US$ Million), 2022 – 2030
Sample Outlook
On the basis of sample, the global HIV diagnostics market has been categorised into urine, blood and saliva. In majority of cases, the HIV tests can be detected through blood or saliva. Though it can also be diagnosed through urine. This is why the blood segment accounts for maximum amount of revenue generated by this market.
Product Outlook
The product segment of the global HIV diagnostics market has been divided into consumables and software and instruments. The consumables segment is further divided in assay, and kits and reagents. The kits and reagents segment is forecasted to see growth at the fastest rate over the period of next several years. This is basically because these kits are extremely important in diagnosing the life-threatening disease.
Test Type Outlook
The test type segment of the global HIV diagnostics market has been segmented into antibody tests, antigen/ antibody tests, nucleic acid tests (NAT), CD4 cell count testing, and ELISA test. The nucleic acid tests (NAT) segment generates major chunk of revenue for this market. These test have been successful in providing the most precise diagnosis and hence preferred the most by medical experts.
Distribution Channel Outlook
The distribution channel segment of the global HIV diagnostics market has been divided into online and offline. The offline segment dominates largely as number of diagnostic kits suppliers working offline are on the higher side. Though the online segment is forecasted to see growth at the fastest rate.
End Users Outlook
The end users’ segment of the global HIV diagnostics market has been bifurcated into diagnostic laboratories, hospitals, blood banks, homecare settings and others. The diagnostic laboratories segment has been successful in generating most of the money for this market. They are easiest option for those who want themselves get checked for the infection.
Region Outlook
On the basis of region, the global HIV diagnostics market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America has been accounting for the most of the revenue for this market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global HIV diagnostics market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Competitors: Global HIV Diagnostics Market
- Abbott
- BD
- Beckman Coulter, Inc.
- Bio-Rad Laboratories
- Bristol Myers Squibb
- Chembio Diagnostics, Inc
- Hoffmann-La Roche Ltd
- Janssen Pharmaceutica NV
- Merck & Co. Inc.
- OraSure Technologies, Inc.
- QIAGEN
- Siemens Healthcare Private Limited
- Other Market Participants
Global HIV Diagnostics Market
By Types
- HIV-1
- HIV-2
By Sample
- Urine
- Blood
- Saliva
By Product
- Consumables
- Assay
- Kits and Reagents
- Software and Instruments
By Test Type
- Antibody tests
- Antigen/ antibody tests
- Nucleic Acid Tests (NAT)
- CD4 cell count testing
- ELISA Test
By Distribution Channel
- Online
- Offline
By End User
- Diagnostic Laboratories
- Hospitals
- Blood Banks
- Homecare Settings
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 - 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of HIV Diagnostics Market
6. Market Synopsis: HIV
Diagnostics Market
7. HIV Diagnostics Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
HIV Diagnostics Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: HIV Diagnostics Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on HIV Diagnostics Market
8. Global HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
8.1. Overview
8.1.1. Global
HIV Diagnostics Market Revenue (US$ Mn)
8.2. Global HIV
Diagnostics Market Revenue (US$ Mn) and Forecasts, By Types
8.2.1. HIV-1
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 - 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 - 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 - 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 - 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 - 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 - 2030
8.2.2. HIV-2
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 - 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By Types
9. Global HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
9.1. Overview
9.2. Global HIV
Diagnostics Market Revenue (US$ Mn) and Forecasts, By Sample
9.2.1. Urine
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 - 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Blood
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 - 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Saliva
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 - 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Sample
10. Global HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
10.1. Overview
10.2. Global
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
10.2.1. Consumables
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Assay , Kits and Reagents )
10.2.1.1. Assay
10.2.1.2. Kits and Reagents
10.2.2. Software
and Instruments
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 - 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Product
11. Global HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
11.1. Overview
11.2. Global
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Test Type
11.2.1. Antibody
tests
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 - 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Antigen/antibody
tests
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 - 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.2.3. Nucleic
Acid Tests (NAT)
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 - 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 - 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 - 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 - 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 - 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 - 2030
11.2.4. CD4
cell count testing
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2021
11.2.4.3. Market Forecast, 2022 - 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2021
11.2.4.5.1.2. Market
Forecast, 2022 - 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2021
11.2.4.5.2.2. Market
Forecast, 2022 - 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2021
11.2.4.5.3.2. Market
Forecast, 2022 - 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2021
11.2.4.5.4.2. Market
Forecast, 2022 - 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2021
11.2.4.5.5.2. Market
Forecast, 2022 - 2030
11.2.5. ELISA
Test
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2021
11.2.5.3. Market Forecast, 2022 - 2030
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2021
11.2.5.5.1.2. Market
Forecast, 2022 - 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2021
11.2.5.5.2.2. Market
Forecast, 2022 - 2030
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2021
11.2.5.5.3.2. Market
Forecast, 2022 - 2030
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2021
11.2.5.5.4.2. Market
Forecast, 2022 - 2030
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2021
11.2.5.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key Segment
for Channeling Investments
11.3.1. By Test
Type
12. Global HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
12.1. Overview
12.2. Global
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
12.2.1. Online
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2021
12.2.1.3. Market Forecast, 2022 - 2030
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 - 2021
12.2.1.5.1.2. Market
Forecast, 2022 - 2030
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2021
12.2.1.5.2.2. Market
Forecast, 2022 - 2030
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2021
12.2.1.5.3.2. Market
Forecast, 2022 - 2030
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2021
12.2.1.5.4.2. Market
Forecast, 2022 - 2030
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 - 2021
12.2.1.5.5.2. Market
Forecast, 2022 - 2030
12.2.2. Offline
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2021
12.2.2.3. Market Forecast, 2022 - 2030
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 - 2021
12.2.2.5.1.2. Market
Forecast, 2022 - 2030
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2021
12.2.2.5.2.2. Market
Forecast, 2022 - 2030
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2021
12.2.2.5.3.2. Market
Forecast, 2022 - 2030
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2021
12.2.2.5.4.2. Market
Forecast, 2022 - 2030
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 - 2021
12.2.2.5.5.2. Market
Forecast, 2022 - 2030
12.3. Key
Segment for Channeling Investments
12.3.1. By
Distribution Channel
13. Global HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
13.1. Overview
13.2. Global
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By End Users
13.2.1. Diagnostic
Laboratories
13.2.1.1. Definition
13.2.1.2. Market Estimation and Penetration, 2015 - 2021
13.2.1.3. Market Forecast, 2022 - 2030
13.2.1.4. Compound Annual Growth Rate (CAGR)
13.2.1.5. Regional Bifurcation
13.2.1.5.1. North America
13.2.1.5.1.1. Market
Estimation, 2015 - 2021
13.2.1.5.1.2. Market
Forecast, 2022 - 2030
13.2.1.5.2. Europe
13.2.1.5.2.1. Market
Estimation, 2015 - 2021
13.2.1.5.2.2. Market
Forecast, 2022 - 2030
13.2.1.5.3. Asia Pacific
13.2.1.5.3.1. Market
Estimation, 2015 - 2021
13.2.1.5.3.2. Market
Forecast, 2022 - 2030
13.2.1.5.4. Middle East and Africa
13.2.1.5.4.1. Market
Estimation, 2015 - 2021
13.2.1.5.4.2. Market
Forecast, 2022 - 2030
13.2.1.5.5. Latin America
13.2.1.5.5.1. Market
Estimation, 2015 - 2021
13.2.1.5.5.2. Market
Forecast, 2022 - 2030
13.2.2. Hospitals
13.2.2.1. Definition
13.2.2.2. Market Estimation and Penetration, 2015 - 2021
13.2.2.3. Market Forecast, 2022 - 2030
13.2.2.4. Compound Annual Growth Rate (CAGR)
13.2.2.5. Regional Bifurcation
13.2.2.5.1. North America
13.2.2.5.1.1. Market
Estimation, 2015 - 2021
13.2.2.5.1.2. Market
Forecast, 2022 - 2030
13.2.2.5.2. Europe
13.2.2.5.2.1. Market
Estimation, 2015 - 2021
13.2.2.5.2.2. Market
Forecast, 2022 - 2030
13.2.2.5.3. Asia Pacific
13.2.2.5.3.1. Market
Estimation, 2015 - 2021
13.2.2.5.3.2. Market
Forecast, 2022 - 2030
13.2.2.5.4. Middle East and Africa
13.2.2.5.4.1. Market
Estimation, 2015 - 2021
13.2.2.5.4.2. Market
Forecast, 2022 - 2030
13.2.2.5.5. Latin America
13.2.2.5.5.1. Market
Estimation, 2015 - 2021
13.2.2.5.5.2. Market
Forecast, 2022 - 2030
13.2.3. Blood
Banks
13.2.3.1. Definition
13.2.3.2. Market Estimation and Penetration, 2015 - 2021
13.2.3.3. Market Forecast, 2022 - 2030
13.2.3.4. Compound Annual Growth Rate (CAGR)
13.2.3.5. Regional Bifurcation
13.2.3.5.1. North America
13.2.3.5.1.1. Market
Estimation, 2015 - 2021
13.2.3.5.1.2. Market
Forecast, 2022 - 2030
13.2.3.5.2. Europe
13.2.3.5.2.1. Market
Estimation, 2015 - 2021
13.2.3.5.2.2. Market
Forecast, 2022 - 2030
13.2.3.5.3. Asia Pacific
13.2.3.5.3.1. Market
Estimation, 2015 - 2021
13.2.3.5.3.2. Market
Forecast, 2022 - 2030
13.2.3.5.4. Middle East and Africa
13.2.3.5.4.1. Market
Estimation, 2015 - 2021
13.2.3.5.4.2. Market
Forecast, 2022 - 2030
13.2.3.5.5. Latin America
13.2.3.5.5.1. Market
Estimation, 2015 - 2021
13.2.3.5.5.2. Market
Forecast, 2022 - 2030
13.2.4. Homecare
Settings
13.2.4.1. Definition
13.2.4.2. Market Estimation and Penetration, 2015 - 2021
13.2.4.3. Market Forecast, 2022 - 2030
13.2.4.4. Compound Annual Growth Rate (CAGR)
13.2.4.5. Regional Bifurcation
13.2.4.5.1. North America
13.2.4.5.1.1. Market
Estimation, 2015 - 2021
13.2.4.5.1.2. Market
Forecast, 2022 - 2030
13.2.4.5.2. Europe
13.2.4.5.2.1. Market
Estimation, 2015 - 2021
13.2.4.5.2.2. Market
Forecast, 2022 - 2030
13.2.4.5.3. Asia Pacific
13.2.4.5.3.1. Market
Estimation, 2015 - 2021
13.2.4.5.3.2. Market
Forecast, 2022 - 2030
13.2.4.5.4. Middle East and Africa
13.2.4.5.4.1. Market
Estimation, 2015 - 2021
13.2.4.5.4.2. Market
Forecast, 2022 - 2030
13.2.4.5.5. Latin America
13.2.4.5.5.1. Market
Estimation, 2015 - 2021
13.2.4.5.5.2. Market
Forecast, 2022 - 2030
13.2.5. Others
13.2.5.1. Definition
13.2.5.2. Market Estimation and Penetration, 2015 - 2021
13.2.5.3. Market Forecast, 2022 - 2030
13.2.5.4. Compound Annual Growth Rate (CAGR)
13.2.5.5. Regional Bifurcation
13.2.5.5.1. North America
13.2.5.5.1.1. Market
Estimation, 2015 - 2021
13.2.5.5.1.2. Market
Forecast, 2022 - 2030
13.2.5.5.2. Europe
13.2.5.5.2.1. Market
Estimation, 2015 - 2021
13.2.5.5.2.2. Market
Forecast, 2022 - 2030
13.2.5.5.3. Asia Pacific
13.2.5.5.3.1. Market
Estimation, 2015 - 2021
13.2.5.5.3.2. Market
Forecast, 2022 - 2030
13.2.5.5.4. Middle East and Africa
13.2.5.5.4.1. Market
Estimation, 2015 - 2021
13.2.5.5.4.2. Market
Forecast, 2022 - 2030
13.2.5.5.5. Latin America
13.2.5.5.5.1. Market
Estimation, 2015 - 2021
13.2.5.5.5.2. Market
Forecast, 2022 - 2030
13.3. Key
Segment for Channeling Investments
13.3.1. By End
Users
14. North America HIV Diagnostics Market Analysis and Forecasts, 2022
- 2030
14.1. Overview
14.1.1. North
America HIV Diagnostics Market Revenue (US$ Mn)
14.2. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Types
14.2.1. HIV-1
14.2.2. HIV-2
14.3. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Sample
14.3.1. Urine
14.3.2. Blood
14.3.3. Saliva
14.4. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
14.4.1. Consumables
14.4.1.1. Assay
14.4.1.2. Kits and Reagents
14.4.2. Software
and Instruments
14.5. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Test Type
14.5.1. Antibody
tests
14.5.2. Antigen/antibody
tests
14.5.3. Nucleic
Acid Tests (NAT)
14.5.4. CD4
cell count testing
14.5.5. ELISA
Test
14.6. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.1. Online
14.6.2. Offline
14.7. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.1. Diagnostic
Laboratories
14.7.2. Hospitals
14.7.3. Blood
Banks
14.7.4. Homecare
Settings
14.7.5. Others
14.8. North
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
14.8.1. U.S
14.8.1.1. U.S HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Types
14.8.1.1.1. HIV-1
14.8.1.1.2. HIV-2
14.8.1.2. U.S HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Sample
14.8.1.2.1. Urine
14.8.1.2.2. Blood
14.8.1.2.3. Saliva
14.8.1.3. U.S HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Product
14.8.1.3.1. Consumables
14.8.1.3.1.1. Assay
14.8.1.3.1.2. Kits
and Reagents
14.8.1.3.2. Software and Instruments
14.8.1.4. U.S HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Test Type
14.8.1.4.1. Antibody tests
14.8.1.4.2. Antigen/antibody tests
14.8.1.4.3. Nucleic Acid Tests (NAT)
14.8.1.4.4. CD4 cell count testing
14.8.1.4.5. ELISA Test
14.8.1.5. U.S HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.8.1.5.1. Online
14.8.1.5.2. Offline
14.8.1.6. U.S HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
End Users
14.8.1.6.1. Diagnostic Laboratories
14.8.1.6.2. Hospitals
14.8.1.6.3. Blood Banks
14.8.1.6.4. Homecare Settings
14.8.1.6.5. Others
14.8.2. Canada
14.8.2.1. Canada HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
14.8.2.1.1. HIV-1
14.8.2.1.2. HIV-2
14.8.2.2. Canada HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
14.8.2.2.1. Urine
14.8.2.2.2. Blood
14.8.2.2.3. Saliva
14.8.2.3. Canada HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
14.8.2.3.1. Consumables
14.8.2.3.1.1. Assay
14.8.2.3.1.2. Kits
and Reagents
14.8.2.3.2. Software and Instruments
14.8.2.4. Canada HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
14.8.2.4.1. Antibody tests
14.8.2.4.2. Antigen/antibody tests
14.8.2.4.3. Nucleic Acid Tests (NAT)
14.8.2.4.4. CD4 cell count testing
14.8.2.4.5. ELISA Test
14.8.2.5. Canada HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.8.2.5.1. Online
14.8.2.5.2. Offline
14.8.2.6. Canada HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
14.8.2.6.1. Diagnostic Laboratories
14.8.2.6.2. Hospitals
14.8.2.6.3. Blood Banks
14.8.2.6.4. Homecare Settings
14.8.2.6.5. Others
14.8.3. Mexico
14.8.3.1. Mexico HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
14.8.3.1.1. HIV-1
14.8.3.1.2. HIV-2
14.8.3.2. Mexico HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
14.8.3.2.1. Urine
14.8.3.2.2. Blood
14.8.3.2.3. Saliva
14.8.3.3. Mexico HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
14.8.3.3.1. Consumables
14.8.3.3.1.1. Assay
14.8.3.3.1.2. Kits
and Reagents
14.8.3.3.2. Software and Instruments
14.8.3.4. Mexico HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
14.8.3.4.1. Antibody tests
14.8.3.4.2. Antigen/antibody tests
14.8.3.4.3. Nucleic Acid Tests (NAT)
14.8.3.4.4. CD4 cell count testing
14.8.3.4.5. ELISA Test
14.8.3.5. Mexico HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.8.3.5.1. Online
14.8.3.5.2. Offline
14.8.3.6. Mexico HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
14.8.3.6.1. Diagnostic Laboratories
14.8.3.6.2. Hospitals
14.8.3.6.3. Blood Banks
14.8.3.6.4. Homecare Settings
14.8.3.6.5. Others
14.8.4. Rest of
North America
14.8.4.1. Rest of North America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Types
14.8.4.1.1. HIV-1
14.8.4.1.2. HIV-2
14.8.4.2. Rest of North America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Sample
14.8.4.2.1. Urine
14.8.4.2.2. Blood
14.8.4.2.3. Saliva
14.8.4.3. Rest of North America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Product
14.8.4.3.1. Consumables
14.8.4.3.1.1. Assay
14.8.4.3.1.2. Kits
and Reagents
14.8.4.3.2. Software and Instruments
14.8.4.4. Rest of North America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Test Type
14.8.4.4.1. Antibody tests
14.8.4.4.2. Antigen/antibody tests
14.8.4.4.3. Nucleic Acid Tests (NAT)
14.8.4.4.4. CD4 cell count testing
14.8.4.4.5. ELISA Test
14.8.4.5. Rest of North America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
14.8.4.5.1. Online
14.8.4.5.2. Offline
14.8.4.6. Rest of North America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By End Users
14.8.4.6.1. Diagnostic Laboratories
14.8.4.6.2. Hospitals
14.8.4.6.3. Blood Banks
14.8.4.6.4. Homecare Settings
14.8.4.6.5. Others
14.9. Key
Segment for Channeling Investments
14.9.1. By
Country
14.9.2. By
Types
14.9.3. By
Sample
14.9.4. By
Product
14.9.5. By Test
Type
14.9.6. By
Distribution Channel
14.9.7. By End
Users
15. Europe HIV Diagnostics Market Analysis and Forecasts, 2022 -
2030
15.1. Overview
15.1.1. Europe
HIV Diagnostics Market Revenue (US$ Mn)
15.2. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Types
15.2.1. HIV-1
15.2.2. HIV-2
15.3. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Sample
15.3.1. Urine
15.3.2. Blood
15.3.3. Saliva
15.4. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
15.4.1. Consumables
15.4.1.1. Assay
15.4.1.2. Kits and Reagents
15.4.2. Software
and Instruments
15.5. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Test Type
15.5.1. Antibody
tests
15.5.2. Antigen/antibody
tests
15.5.3. Nucleic
Acid Tests (NAT)
15.5.4. CD4
cell count testing
15.5.5. ELISA
Test
15.6. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.6.1. Online
15.6.2. Offline
15.7. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.1. Diagnostic
Laboratories
15.7.2. Hospitals
15.7.3. Blood
Banks
15.7.4. Homecare
Settings
15.7.5. Others
15.8. Europe
HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
15.8.1. France
15.8.1.1. France HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
15.8.1.1.1. HIV-1
15.8.1.1.2. HIV-2
15.8.1.2. France HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
15.8.1.2.1. Urine
15.8.1.2.2. Blood
15.8.1.2.3. Saliva
15.8.1.3. France HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
15.8.1.3.1. Consumables
15.8.1.3.1.1. Assay
15.8.1.3.1.2. Kits
and Reagents
15.8.1.3.2. Software and Instruments
15.8.1.4. France HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
15.8.1.4.1. Antibody tests
15.8.1.4.2. Antigen/antibody tests
15.8.1.4.3. Nucleic Acid Tests (NAT)
15.8.1.4.4. CD4 cell count testing
15.8.1.4.5. ELISA Test
15.8.1.5. France HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.8.1.5.1. Online
15.8.1.5.2. Offline
15.8.1.6. France HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
15.8.1.6.1. Diagnostic Laboratories
15.8.1.6.2. Hospitals
15.8.1.6.3. Blood Banks
15.8.1.6.4. Homecare Settings
15.8.1.6.5. Others
15.8.2. The UK
15.8.2.1. The UK HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
15.8.2.1.1. HIV-1
15.8.2.1.2. HIV-2
15.8.2.2. The UK HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
15.8.2.2.1. Urine
15.8.2.2.2. Blood
15.8.2.2.3. Saliva
15.8.2.3. The UK HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
15.8.2.3.1. Consumables
15.8.2.3.1.1. Assay
15.8.2.3.1.2. Kits
and Reagents
15.8.2.3.2. Software and Instruments
15.8.2.4. The UK HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
15.8.2.4.1. Antibody tests
15.8.2.4.2. Antigen/antibody tests
15.8.2.4.3. Nucleic Acid Tests (NAT)
15.8.2.4.4. CD4 cell count testing
15.8.2.4.5. ELISA Test
15.8.2.5. The UK HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.8.2.5.1. Online
15.8.2.5.2. Offline
15.8.2.6. The UK HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
15.8.2.6.1. Diagnostic Laboratories
15.8.2.6.2. Hospitals
15.8.2.6.3. Blood Banks
15.8.2.6.4. Homecare Settings
15.8.2.6.5. Others
15.8.3. Spain
15.8.3.1. Spain HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
15.8.3.1.1. HIV-1
15.8.3.1.2. HIV-2
15.8.3.2. Spain HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
15.8.3.2.1. Urine
15.8.3.2.2. Blood
15.8.3.2.3. Saliva
15.8.3.3. Spain HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
15.8.3.3.1. Consumables
15.8.3.3.1.1. Assay
15.8.3.3.1.2. Kits
and Reagents
15.8.3.3.2. Software and Instruments
15.8.3.4. Spain HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
15.8.3.4.1. Antibody tests
15.8.3.4.2. Antigen/antibody tests
15.8.3.4.3. Nucleic Acid Tests (NAT)
15.8.3.4.4. CD4 cell count testing
15.8.3.4.5. ELISA Test
15.8.3.5. Spain HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.8.3.5.1. Online
15.8.3.5.2. Offline
15.8.3.6. Spain HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
15.8.3.6.1. Diagnostic Laboratories
15.8.3.6.2. Hospitals
15.8.3.6.3. Blood Banks
15.8.3.6.4. Homecare Settings
15.8.3.6.5. Others
15.8.4. Germany
15.8.4.1. Germany HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
15.8.4.1.1. HIV-1
15.8.4.1.2. HIV-2
15.8.4.2. Germany HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
15.8.4.2.1. Urine
15.8.4.2.2. Blood
15.8.4.2.3. Saliva
15.8.4.3. Germany HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
15.8.4.3.1. Consumables
15.8.4.3.1.1. Assay
15.8.4.3.1.2. Kits
and Reagents
15.8.4.3.2. Software and Instruments
15.8.4.4. Germany HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
15.8.4.4.1. Antibody tests
15.8.4.4.2. Antigen/antibody tests
15.8.4.4.3. Nucleic Acid Tests (NAT)
15.8.4.4.4. CD4 cell count testing
15.8.4.4.5. ELISA Test
15.8.4.5. Germany HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.8.4.5.1. Online
15.8.4.5.2. Offline
15.8.4.6. Germany HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
15.8.4.6.1. Diagnostic Laboratories
15.8.4.6.2. Hospitals
15.8.4.6.3. Blood Banks
15.8.4.6.4. Homecare Settings
15.8.4.6.5. Others
15.8.5. Italy
15.8.5.1. Italy HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
15.8.5.1.1. HIV-1
15.8.5.1.2. HIV-2
15.8.5.2. Italy HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
15.8.5.2.1. Urine
15.8.5.2.2. Blood
15.8.5.2.3. Saliva
15.8.5.3. Italy HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
15.8.5.3.1. Consumables
15.8.5.3.1.1. Assay
15.8.5.3.1.2. Kits
and Reagents
15.8.5.3.2. Software and Instruments
15.8.5.4. Italy HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
15.8.5.4.1. Antibody tests
15.8.5.4.2. Antigen/antibody tests
15.8.5.4.3. Nucleic Acid Tests (NAT)
15.8.5.4.4. CD4 cell count testing
15.8.5.4.5. ELISA Test
15.8.5.5. Italy HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.8.5.5.1. Online
15.8.5.5.2. Offline
15.8.5.6. Italy HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
15.8.5.6.1. Diagnostic Laboratories
15.8.5.6.2. Hospitals
15.8.5.6.3. Blood Banks
15.8.5.6.4. Homecare Settings
15.8.5.6.5. Others
15.8.6. Nordic
Countries
15.8.6.1. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
15.8.6.1.1. HIV-1
15.8.6.1.2. HIV-2
15.8.6.2. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
15.8.6.2.1. Urine
15.8.6.2.2. Blood
15.8.6.2.3. Saliva
15.8.6.3. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
15.8.6.3.1. Consumables
15.8.6.3.1.1. Assay
15.8.6.3.1.2. Kits
and Reagents
15.8.6.3.2. Software and Instruments
15.8.6.4. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
15.8.6.4.1. Antibody tests
15.8.6.4.2. Antigen/antibody tests
15.8.6.4.3. Nucleic Acid Tests (NAT)
15.8.6.4.4. CD4 cell count testing
15.8.6.4.5. ELISA Test
15.8.6.5. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.6.5.1. Online
15.8.6.5.2. Offline
15.8.6.6. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.6.6.1. Diagnostic Laboratories
15.8.6.6.2. Hospitals
15.8.6.6.3. Blood Banks
15.8.6.6.4. Homecare Settings
15.8.6.6.5. Others
15.8.6.7. Nordic Countries HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
15.8.6.7.1. Denmark
15.8.6.7.2. Finland
15.8.6.7.3. Iceland
15.8.6.7.4. Sweden
15.8.6.7.5. Norway
15.8.7. Benelux
Union
15.8.7.1. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
15.8.7.1.1. HIV-1
15.8.7.1.2. HIV-2
15.8.7.2. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
15.8.7.2.1. Urine
15.8.7.2.2. Blood
15.8.7.2.3. Saliva
15.8.7.3. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
15.8.7.3.1. Consumables
15.8.7.3.1.1. Assay
15.8.7.3.1.2. Kits
and Reagents
15.8.7.3.2. Software and Instruments
15.8.7.4. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
15.8.7.4.1. Antibody tests
15.8.7.4.2. Antigen/antibody tests
15.8.7.4.3. Nucleic Acid Tests (NAT)
15.8.7.4.4. CD4 cell count testing
15.8.7.4.5. ELISA Test
15.8.7.5. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.7.5.1. Online
15.8.7.5.2. Offline
15.8.7.6. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.7.6.1. Diagnostic Laboratories
15.8.7.6.2. Hospitals
15.8.7.6.3. Blood Banks
15.8.7.6.4. Homecare Settings
15.8.7.6.5. Others
15.8.7.7. Benelux Union HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
15.8.7.7.1. Belgium
15.8.7.7.2. The Netherlands
15.8.7.7.3. Luxembourg
15.8.8. Rest of
Europe
15.8.8.1. Rest of Europe HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
15.8.8.1.1. HIV-1
15.8.8.1.2. HIV-2
15.8.8.2. Rest of Europe HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
15.8.8.2.1. Urine
15.8.8.2.2. Blood
15.8.8.2.3. Saliva
15.8.8.3. Rest of Europe HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
15.8.8.3.1. Consumables
15.8.8.3.1.1. Assay
15.8.8.3.1.2. Kits
and Reagents
15.8.8.3.2. Software and Instruments
15.8.8.4. Rest of Europe HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
15.8.8.4.1. Antibody tests
15.8.8.4.2. Antigen/antibody tests
15.8.8.4.3. Nucleic Acid Tests (NAT)
15.8.8.4.4. CD4 cell count testing
15.8.8.4.5. ELISA Test
15.8.8.5. Rest of Europe HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.8.5.1. Online
15.8.8.5.2. Offline
15.8.8.6. Rest of Europe HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.8.6.1. Diagnostic Laboratories
15.8.8.6.2. Hospitals
15.8.8.6.3. Blood Banks
15.8.8.6.4. Homecare Settings
15.8.8.6.5. Others
15.9. Key
Segment for Channeling Investments
15.9.1. By
Country
15.9.2. By
Types
15.9.3. By
Sample
15.9.4. By
Product
15.9.5. By Test
Type
15.9.6. By
Distribution Channel
15.9.7. By End
Users
16. Asia Pacific HIV Diagnostics Market Analysis and Forecasts, 2022
- 2030
16.1. Overview
16.1.1. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn)
16.2. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Types
16.2.1. HIV-1
16.2.2. HIV-2
16.3. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Sample
16.3.1. Urine
16.3.2. Blood
16.3.3. Saliva
16.4. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
16.4.1. Consumables
16.4.1.1. Assay
16.4.1.2. Kits and Reagents
16.4.2. Software
and Instruments
16.5. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Test Type
16.5.1. Antibody
tests
16.5.2. Antigen/antibody
tests
16.5.3. Nucleic
Acid Tests (NAT)
16.5.4. CD4
cell count testing
16.5.5. ELISA
Test
16.6. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.6.1. Online
16.6.2. Offline
16.7. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.1. Diagnostic
Laboratories
16.7.2. Hospitals
16.7.3. Blood
Banks
16.7.4. Homecare
Settings
16.7.5. Others
16.8. Asia
Pacific HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
16.8.1. China
16.8.1.1. China HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
16.8.1.1.1. HIV-1
16.8.1.1.2. HIV-2
16.8.1.2. China HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
16.8.1.2.1. Urine
16.8.1.2.2. Blood
16.8.1.2.3. Saliva
16.8.1.3. China HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
16.8.1.3.1. Consumables
16.8.1.3.1.1. Assay
16.8.1.3.1.2. Kits
and Reagents
16.8.1.3.2. Software and Instruments
16.8.1.4. China HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
16.8.1.4.1. Antibody tests
16.8.1.4.2. Antigen/antibody tests
16.8.1.4.3. Nucleic Acid Tests (NAT)
16.8.1.4.4. CD4 cell count testing
16.8.1.4.5. ELISA Test
16.8.1.5. China HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
16.8.1.5.1. Online
16.8.1.5.2. Offline
16.8.1.6. China HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
16.8.1.6.1. Diagnostic Laboratories
16.8.1.6.2. Hospitals
16.8.1.6.3. Blood Banks
16.8.1.6.4. Homecare Settings
16.8.1.6.5. Others
16.8.2. Japan
16.8.2.1. Japan HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
16.8.2.1.1. HIV-1
16.8.2.1.2. HIV-2
16.8.2.2. Japan HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
16.8.2.2.1. Urine
16.8.2.2.2. Blood
16.8.2.2.3. Saliva
16.8.2.3. Japan HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
16.8.2.3.1. Consumables
16.8.2.3.1.1. Assay
16.8.2.3.1.2. Kits
and Reagents
16.8.2.3.2. Software and Instruments
16.8.2.4. Japan HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
16.8.2.4.1. Antibody tests
16.8.2.4.2. Antigen/antibody tests
16.8.2.4.3. Nucleic Acid Tests (NAT)
16.8.2.4.4. CD4 cell count testing
16.8.2.4.5. ELISA Test
16.8.2.5. Japan HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
16.8.2.5.1. Online
16.8.2.5.2. Offline
16.8.2.6. Japan HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
16.8.2.6.1. Diagnostic Laboratories
16.8.2.6.2. Hospitals
16.8.2.6.3. Blood Banks
16.8.2.6.4. Homecare Settings
16.8.2.6.5. Others
16.8.3. India
16.8.3.1. India HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
16.8.3.1.1. HIV-1
16.8.3.1.2. HIV-2
16.8.3.2. India HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
16.8.3.2.1. Urine
16.8.3.2.2. Blood
16.8.3.2.3. Saliva
16.8.3.3. India HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
16.8.3.3.1. Consumables
16.8.3.3.1.1. Assay
16.8.3.3.1.2. Kits
and Reagents
16.8.3.3.2. Software and Instruments
16.8.3.4. India HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
16.8.3.4.1. Antibody tests
16.8.3.4.2. Antigen/antibody tests
16.8.3.4.3. Nucleic Acid Tests (NAT)
16.8.3.4.4. CD4 cell count testing
16.8.3.4.5. ELISA Test
16.8.3.5. India HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
16.8.3.5.1. Online
16.8.3.5.2. Offline
16.8.3.6. India HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
16.8.3.6.1. Diagnostic Laboratories
16.8.3.6.2. Hospitals
16.8.3.6.3. Blood Banks
16.8.3.6.4. Homecare Settings
16.8.3.6.5. Others
16.8.4. New
Zealand
16.8.4.1. New Zealand HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
16.8.4.1.1. HIV-1
16.8.4.1.2. HIV-2
16.8.4.2. New Zealand HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
16.8.4.2.1. Urine
16.8.4.2.2. Blood
16.8.4.2.3. Saliva
16.8.4.3. New Zealand HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
16.8.4.3.1. Consumables
16.8.4.3.1.1. Assay
16.8.4.3.1.2. Kits
and Reagents
16.8.4.3.2. Software and Instruments
16.8.4.4. New Zealand HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
16.8.4.4.1. Antibody tests
16.8.4.4.2. Antigen/antibody tests
16.8.4.4.3. Nucleic Acid Tests (NAT)
16.8.4.4.4. CD4 cell count testing
16.8.4.4.5. ELISA Test
16.8.4.5. New Zealand HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.4.5.1. Online
16.8.4.5.2. Offline
16.8.4.6. New Zealand HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.4.6.1. Diagnostic Laboratories
16.8.4.6.2. Hospitals
16.8.4.6.3. Blood Banks
16.8.4.6.4. Homecare Settings
16.8.4.6.5. Others
16.8.5. Australia
16.8.5.1. Australia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
16.8.5.1.1. HIV-1
16.8.5.1.2. HIV-2
16.8.5.2. Australia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
16.8.5.2.1. Urine
16.8.5.2.2. Blood
16.8.5.2.3. Saliva
16.8.5.3. Australia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
16.8.5.3.1. Consumables
16.8.5.3.1.1. Assay
16.8.5.3.1.2. Kits
and Reagents
16.8.5.3.2. Software and Instruments
16.8.5.4. Australia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
16.8.5.4.1. Antibody tests
16.8.5.4.2. Antigen/antibody tests
16.8.5.4.3. Nucleic Acid Tests (NAT)
16.8.5.4.4. CD4 cell count testing
16.8.5.4.5. ELISA Test
16.8.5.5. Australia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.5.5.1. Online
16.8.5.5.2. Offline
16.8.5.6. Australia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.5.6.1. Diagnostic Laboratories
16.8.5.6.2. Hospitals
16.8.5.6.3. Blood Banks
16.8.5.6.4. Homecare Settings
16.8.5.6.5. Others
16.8.6. South
Korea
16.8.6.1. South Korea HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
16.8.6.1.1. HIV-1
16.8.6.1.2. HIV-2
16.8.6.2. South Korea HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
16.8.6.2.1. Urine
16.8.6.2.2. Blood
16.8.6.2.3. Saliva
16.8.6.3. South Korea HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
16.8.6.3.1. Consumables
16.8.6.3.1.1. Assay
16.8.6.3.1.2. Kits
and Reagents
16.8.6.3.2. Software and Instruments
16.8.6.4. South Korea HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
16.8.6.4.1. Antibody tests
16.8.6.4.2. Antigen/antibody tests
16.8.6.4.3. Nucleic Acid Tests (NAT)
16.8.6.4.4. CD4 cell count testing
16.8.6.4.5. ELISA Test
16.8.6.5. South Korea HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.6.5.1. Online
16.8.6.5.2. Offline
16.8.6.6. South Korea HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.6.6.1. Diagnostic Laboratories
16.8.6.6.2. Hospitals
16.8.6.6.3. Blood Banks
16.8.6.6.4. Homecare Settings
16.8.6.6.5. Others
16.8.7. Southeast
Asia
16.8.7.1. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
16.8.7.1.1. HIV-1
16.8.7.1.2. HIV-2
16.8.7.2. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
16.8.7.2.1. Urine
16.8.7.2.2. Blood
16.8.7.2.3. Saliva
16.8.7.3. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
16.8.7.3.1. Consumables
16.8.7.3.1.1. Assay
16.8.7.3.1.2. Kits
and Reagents
16.8.7.3.2. Software and Instruments
16.8.7.4. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
16.8.7.4.1. Antibody tests
16.8.7.4.2. Antigen/antibody tests
16.8.7.4.3. Nucleic Acid Tests (NAT)
16.8.7.4.4. CD4 cell count testing
16.8.7.4.5. ELISA Test
16.8.7.5. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.7.5.1. Online
16.8.7.5.2. Offline
16.8.7.6. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
16.8.7.6.1. Diagnostic Laboratories
16.8.7.6.2. Hospitals
16.8.7.6.3. Blood Banks
16.8.7.6.4. Homecare Settings
16.8.7.6.5. Others
16.8.7.7. Southeast Asia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Country
16.8.7.7.1. Indonesia
16.8.7.7.2. Thailand
16.8.7.7.3. Malaysia
16.8.7.7.4. Singapore
16.8.7.7.5. Rest of Southeast Asia
16.8.8. Rest of
Asia Pacific
16.8.8.1. Rest of Asia Pacific HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Types
16.8.8.1.1. HIV-1
16.8.8.1.2. HIV-2
16.8.8.2. Rest of Asia Pacific HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Sample
16.8.8.2.1. Urine
16.8.8.2.2. Blood
16.8.8.2.3. Saliva
16.8.8.3. Rest of Asia Pacific HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Product
16.8.8.3.1. Consumables
16.8.8.3.1.1. Assay
16.8.8.3.1.2. Kits
and Reagents
16.8.8.3.2. Software and Instruments
16.8.8.4. Rest of Asia Pacific HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Test Type
16.8.8.4.1. Antibody tests
16.8.8.4.2. Antigen/antibody tests
16.8.8.4.3. Nucleic Acid Tests (NAT)
16.8.8.4.4. CD4 cell count testing
16.8.8.4.5. ELISA Test
16.8.8.5. Rest of Asia Pacific HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
16.8.8.5.1. Online
16.8.8.5.2. Offline
16.8.8.6. Rest of Asia Pacific HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By End Users
16.8.8.6.1. Diagnostic Laboratories
16.8.8.6.2. Hospitals
16.8.8.6.3. Blood Banks
16.8.8.6.4. Homecare Settings
16.8.8.6.5. Others
16.9. Key
Segment for Channeling Investments
16.9.1. By
Country
16.9.2. By
Types
16.9.3. By
Sample
16.9.4. By
Product
16.9.5. By Test
Type
16.9.6. By
Distribution Channel
16.9.7. By End
Users
17. Middle East and Africa HIV Diagnostics Market Analysis and
Forecasts, 2022 - 2030
17.1. Overview
17.1.1. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn)
17.2. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Types
17.2.1. HIV-1
17.2.2. HIV-2
17.3. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Sample
17.3.1. Urine
17.3.2. Blood
17.3.3. Saliva
17.4. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Product
17.4.1. Consumables
17.4.1.1. Assay
17.4.1.2. Kits and Reagents
17.4.2. Software
and Instruments
17.5. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Test
Type
17.5.1. Antibody
tests
17.5.2. Antigen/antibody
tests
17.5.3. Nucleic
Acid Tests (NAT)
17.5.4. CD4
cell count testing
17.5.5. ELISA
Test
17.6. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.6.1. Online
17.6.2. Offline
17.7. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By End
Users
17.7.1. Diagnostic
Laboratories
17.7.2. Hospitals
17.7.3. Blood
Banks
17.7.4. Homecare
Settings
17.7.5. Others
17.8. Middle
East and Africa HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Country
17.8.1. Saudi
Arabia
17.8.1.1. Saudi Arabia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
17.8.1.1.1. HIV-1
17.8.1.1.2. HIV-2
17.8.1.2. Saudi Arabia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
17.8.1.2.1. Urine
17.8.1.2.2. Blood
17.8.1.2.3. Saliva
17.8.1.3. Saudi Arabia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
17.8.1.3.1. Consumables
17.8.1.3.1.1. Assay
17.8.1.3.1.2. Kits
and Reagents
17.8.1.3.2. Software and Instruments
17.8.1.4. Saudi Arabia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
17.8.1.4.1. Antibody tests
17.8.1.4.2. Antigen/antibody tests
17.8.1.4.3. Nucleic Acid Tests (NAT)
17.8.1.4.4. CD4 cell count testing
17.8.1.4.5. ELISA Test
17.8.1.5. Saudi Arabia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.8.1.5.1. Online
17.8.1.5.2. Offline
17.8.1.6. Saudi Arabia HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
17.8.1.6.1. Diagnostic Laboratories
17.8.1.6.2. Hospitals
17.8.1.6.3. Blood Banks
17.8.1.6.4. Homecare Settings
17.8.1.6.5. Others
17.8.2. UAE
17.8.2.1. UAE HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Types
17.8.2.1.1. HIV-1
17.8.2.1.2. HIV-2
17.8.2.2. UAE HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Sample
17.8.2.2.1. Urine
17.8.2.2.2. Blood
17.8.2.2.3. Saliva
17.8.2.3. UAE HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Product
17.8.2.3.1. Consumables
17.8.2.3.1.1. Assay
17.8.2.3.1.2. Kits
and Reagents
17.8.2.3.2. Software and Instruments
17.8.2.4. UAE HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Test Type
17.8.2.4.1. Antibody tests
17.8.2.4.2. Antigen/antibody tests
17.8.2.4.3. Nucleic Acid Tests (NAT)
17.8.2.4.4. CD4 cell count testing
17.8.2.4.5. ELISA Test
17.8.2.5. UAE HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
17.8.2.5.1. Online
17.8.2.5.2. Offline
17.8.2.6. UAE HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By
End Users
17.8.2.6.1. Diagnostic Laboratories
17.8.2.6.2. Hospitals
17.8.2.6.3. Blood Banks
17.8.2.6.4. Homecare Settings
17.8.2.6.5. Others
17.8.3. Egypt
17.8.3.1. Egypt HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
17.8.3.1.1. HIV-1
17.8.3.1.2. HIV-2
17.8.3.2. Egypt HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
17.8.3.2.1. Urine
17.8.3.2.2. Blood
17.8.3.2.3. Saliva
17.8.3.3. Egypt HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
17.8.3.3.1. Consumables
17.8.3.3.1.1. Assay
17.8.3.3.1.2. Kits
and Reagents
17.8.3.3.2. Software and Instruments
17.8.3.4. Egypt HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
17.8.3.4.1. Antibody tests
17.8.3.4.2. Antigen/antibody tests
17.8.3.4.3. Nucleic Acid Tests (NAT)
17.8.3.4.4. CD4 cell count testing
17.8.3.4.5. ELISA Test
17.8.3.5. Egypt HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
17.8.3.5.1. Online
17.8.3.5.2. Offline
17.8.3.6. Egypt HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
17.8.3.6.1. Diagnostic Laboratories
17.8.3.6.2. Hospitals
17.8.3.6.3. Blood Banks
17.8.3.6.4. Homecare Settings
17.8.3.6.5. Others
17.8.4. Kuwait
17.8.4.1. Kuwait HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
17.8.4.1.1. HIV-1
17.8.4.1.2. HIV-2
17.8.4.2. Kuwait HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
17.8.4.2.1. Urine
17.8.4.2.2. Blood
17.8.4.2.3. Saliva
17.8.4.3. Kuwait HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
17.8.4.3.1. Consumables
17.8.4.3.1.1. Assay
17.8.4.3.1.2. Kits
and Reagents
17.8.4.3.2. Software and Instruments
17.8.4.4. Kuwait HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
17.8.4.4.1. Antibody tests
17.8.4.4.2. Antigen/antibody tests
17.8.4.4.3. Nucleic Acid Tests (NAT)
17.8.4.4.4. CD4 cell count testing
17.8.4.4.5. ELISA Test
17.8.4.5. Kuwait HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
17.8.4.5.1. Online
17.8.4.5.2. Offline
17.8.4.6. Kuwait HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
17.8.4.6.1. Diagnostic Laboratories
17.8.4.6.2. Hospitals
17.8.4.6.3. Blood Banks
17.8.4.6.4. Homecare Settings
17.8.4.6.5. Others
17.8.5. South
Africa
17.8.5.1. South Africa HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
17.8.5.1.1. HIV-1
17.8.5.1.2. HIV-2
17.8.5.2. South Africa HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
17.8.5.2.1. Urine
17.8.5.2.2. Blood
17.8.5.2.3. Saliva
17.8.5.3. South Africa HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
17.8.5.3.1. Consumables
17.8.5.3.1.1. Assay
17.8.5.3.1.2. Kits
and Reagents
17.8.5.3.2. Software and Instruments
17.8.5.4. South Africa HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
17.8.5.4.1. Antibody tests
17.8.5.4.2. Antigen/antibody tests
17.8.5.4.3. Nucleic Acid Tests (NAT)
17.8.5.4.4. CD4 cell count testing
17.8.5.4.5. ELISA Test
17.8.5.5. South Africa HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.8.5.5.1. Online
17.8.5.5.2. Offline
17.8.5.6. South Africa HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
17.8.5.6.1. Diagnostic Laboratories
17.8.5.6.2. Hospitals
17.8.5.6.3. Blood Banks
17.8.5.6.4. Homecare Settings
17.8.5.6.5. Others
17.8.6. Rest of
Middle East & Africa
17.8.6.1. Rest of Middle East & Africa HIV Diagnostics Market
Revenue (US$ Mn) and Forecasts, By Types
17.8.6.1.1. HIV-1
17.8.6.1.2. HIV-2
17.8.6.2. Rest of Middle East & Africa HIV Diagnostics Market
Revenue (US$ Mn) and Forecasts, By Sample
17.8.6.2.1. Urine
17.8.6.2.2. Blood
17.8.6.2.3. Saliva
17.8.6.3. Rest of Middle East & Africa HIV Diagnostics Market
Revenue (US$ Mn) and Forecasts, By Product
17.8.6.3.1. Consumables
17.8.6.3.1.1. Assay
17.8.6.3.1.2. Kits
and Reagents
17.8.6.3.2. Software and Instruments
17.8.6.4. Rest of Middle East & Africa HIV Diagnostics Market
Revenue (US$ Mn) and Forecasts, By Test Type
17.8.6.4.1. Antibody tests
17.8.6.4.2. Antigen/antibody tests
17.8.6.4.3. Nucleic Acid Tests (NAT)
17.8.6.4.4. CD4 cell count testing
17.8.6.4.5. ELISA Test
17.8.6.5. Rest of Middle East & Africa HIV Diagnostics Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
17.8.6.5.1. Online
17.8.6.5.2. Offline
17.8.6.6. Rest of Middle East & Africa HIV Diagnostics Market
Revenue (US$ Mn) and Forecasts, By End Users
17.8.6.6.1. Diagnostic Laboratories
17.8.6.6.2. Hospitals
17.8.6.6.3. Blood Banks
17.8.6.6.4. Homecare Settings
17.8.6.6.5. Others
17.9. Key
Segment for Channeling Investments
17.9.1. By
Country
17.9.2. By
Types
17.9.3. By
Sample
17.9.4. By
Product
17.9.5. By Test
Type
17.9.6. By
Distribution Channel
17.9.7. By End
Users
18. Latin America HIV Diagnostics Market Analysis and Forecasts, 2022
- 2030
18.1. Overview
18.1.1. Latin
America HIV Diagnostics Market Revenue (US$ Mn)
18.2. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Types
18.2.1. HIV-1
18.2.2. HIV-2
18.3. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Sample
18.3.1. Urine
18.3.2. Blood
18.3.3. Saliva
18.4. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Product
18.4.1. Consumables
18.4.1.1. Assay
18.4.1.2. Kits and Reagents
18.4.2. Software
and Instruments
18.5. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Test Type
18.5.1. Antibody
tests
18.5.2. Antigen/antibody
tests
18.5.3. Nucleic
Acid Tests (NAT)
18.5.4. CD4
cell count testing
18.5.5. ELISA
Test
18.6. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
18.6.1. Online
18.6.2. Offline
18.7. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By End Users
18.7.1. Diagnostic
Laboratories
18.7.2. Hospitals
18.7.3. Blood
Banks
18.7.4. Homecare
Settings
18.7.5. Others
18.8. Latin
America HIV Diagnostics Market Revenue (US$ Mn) and Forecasts, By Country
18.8.1. Brazil
18.8.1.1. Brazil HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Types
18.8.1.1.1. HIV-1
18.8.1.1.2. HIV-2
18.8.1.2. Brazil HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Sample
18.8.1.2.1. Urine
18.8.1.2.2. Blood
18.8.1.2.3. Saliva
18.8.1.3. Brazil HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Product
18.8.1.3.1. Consumables
18.8.1.3.1.1. Assay
18.8.1.3.1.2. Kits
and Reagents
18.8.1.3.2. Software and Instruments
18.8.1.4. Brazil HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Test Type
18.8.1.4.1. Antibody tests
18.8.1.4.2. Antigen/antibody tests
18.8.1.4.3. Nucleic Acid Tests (NAT)
18.8.1.4.4. CD4 cell count testing
18.8.1.4.5. ELISA Test
18.8.1.5. Brazil HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
18.8.1.5.1. Online
18.8.1.5.2. Offline
18.8.1.6. Brazil HIV Diagnostics Market Revenue (US$ Mn) and Forecasts,
By End Users
18.8.1.6.1. Diagnostic Laboratories
18.8.1.6.2. Hospitals
18.8.1.6.3. Blood Banks
18.8.1.6.4. Homecare Settings
18.8.1.6.5. Others
18.8.2. Argentina
18.8.2.1. Argentina HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Types
18.8.2.1.1. HIV-1
18.8.2.1.2. HIV-2
18.8.2.2. Argentina HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Sample
18.8.2.2.1. Urine
18.8.2.2.2. Blood
18.8.2.2.3. Saliva
18.8.2.3. Argentina HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Product
18.8.2.3.1. Consumables
18.8.2.3.1.1. Assay
18.8.2.3.1.2. Kits
and Reagents
18.8.2.3.2. Software and Instruments
18.8.2.4. Argentina HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Test Type
18.8.2.4.1. Antibody tests
18.8.2.4.2. Antigen/antibody tests
18.8.2.4.3. Nucleic Acid Tests (NAT)
18.8.2.4.4. CD4 cell count testing
18.8.2.4.5. ELISA Test
18.8.2.5. Argentina HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
18.8.2.5.1. Online
18.8.2.5.2. Offline
18.8.2.6. Argentina HIV Diagnostics Market Revenue (US$ Mn) and
Forecasts, By End Users
18.8.2.6.1. Diagnostic Laboratories
18.8.2.6.2. Hospitals
18.8.2.6.3. Blood Banks
18.8.2.6.4. Homecare Settings
18.8.2.6.5. Others
18.8.3. Rest of
Latin America
18.8.3.1. Rest of Latin America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Types
18.8.3.1.1. HIV-1
18.8.3.1.2. HIV-2
18.8.3.2. Rest of Latin America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Sample
18.8.3.2.1. Urine
18.8.3.2.2. Blood
18.8.3.2.3. Saliva
18.8.3.3. Rest of Latin America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Product
18.8.3.3.1. Consumables
18.8.3.3.1.1. Assay
18.8.3.3.1.2. Kits
and Reagents
18.8.3.3.2. Software and Instruments
18.8.3.4. Rest of Latin America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Test Type
18.8.3.4.1. Antibody tests
18.8.3.4.2. Antigen/antibody tests
18.8.3.4.3. Nucleic Acid Tests (NAT)
18.8.3.4.4. CD4 cell count testing
18.8.3.4.5. ELISA Test
18.8.3.5. Rest of Latin America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
18.8.3.5.1. Online
18.8.3.5.2. Offline
18.8.3.6. Rest of Latin America HIV Diagnostics Market Revenue (US$ Mn)
and Forecasts, By End Users
18.8.3.6.1. Diagnostic Laboratories
18.8.3.6.2. Hospitals
18.8.3.6.3. Blood Banks
18.8.3.6.4. Homecare Settings
18.8.3.6.5. Others
18.9. Key
Segment for Channeling Investments
18.9.1. By
Country
18.9.2. By
Types
18.9.3. By
Sample
18.9.4. By
Product
18.9.5. By Test
Type
18.9.6. By
Distribution Channel
18.9.7. By End
Users
19. Competitive Benchmarking
19.1. Brand
Benchmarking
19.2. Market
Share Analysis, 2021
19.3. Global
Presence and Growth Strategies
19.3.1. Mergers
and Acquisitions
19.3.2. Product
Launches
19.3.3. Investments
Trends
19.3.4. R&D
Initiatives
20. Player Profiles
20.1. Abbott
20.1.1. Company
Details
20.1.2. Company
Overview
20.1.3. Product
Offerings
20.1.4. Key
Developments
20.1.5. Financial
Analysis
20.1.6. SWOT
Analysis
20.1.7. Business
Strategies
20.2. Bio-Rad
Laboratories, Inc.
20.2.1. Company
Details
20.2.2. Company
Overview
20.2.3. Product
Offerings
20.2.4. Key
Developments
20.2.5. Financial
Analysis
20.2.6. SWOT
Analysis
20.2.7. Business
Strategies
20.3. Siemens
Healthcare Private Limited
20.3.1. Company
Details
20.3.2. Company
Overview
20.3.3. Product
Offerings
20.3.4. Key
Developments
20.3.5. Financial
Analysis
20.3.6. SWOT
Analysis
20.3.7. Business
Strategies
20.4. F.
Hoffmann-La Roche Ltd
20.4.1. Company
Details
20.4.2. Company
Overview
20.4.3. Product
Offerings
20.4.4. Key
Developments
20.4.5. Financial
Analysis
20.4.6. SWOT
Analysis
20.4.7. Business
Strategies
20.5. Beckman
Coulter, Inc.
20.5.1. Company
Details
20.5.2. Company
Overview
20.5.3. Product
Offerings
20.5.4. Key
Developments
20.5.5. Financial
Analysis
20.5.6. SWOT
Analysis
20.5.7. Business
Strategies
20.6. OraSure
Technologies, Inc.
20.6.1. Company
Details
20.6.2. Company
Overview
20.6.3. Product
Offerings
20.6.4. Key
Developments
20.6.5. Financial
Analysis
20.6.6. SWOT
Analysis
20.6.7. Business
Strategies
20.7. BD
20.7.1. Company
Details
20.7.2. Company
Overview
20.7.3. Product
Offerings
20.7.4. Key
Developments
20.7.5. Financial
Analysis
20.7.6. SWOT
Analysis
20.7.7. Business
Strategies
20.8. Merck
& Co., Inc.
20.8.1. Company
Details
20.8.2. Company
Overview
20.8.3. Product
Offerings
20.8.4. Key
Developments
20.8.5. Financial
Analysis
20.8.6. SWOT
Analysis
20.8.7. Business
Strategies
20.9. Chembio
Diagnostics, Inc
20.9.1. Company
Details
20.9.2. Company
Overview
20.9.3. Product
Offerings
20.9.4. Key
Developments
20.9.5. Financial
Analysis
20.9.6. SWOT
Analysis
20.9.7. Business
Strategies
20.10. Bristol
Myers Squibb
20.10.1. Company
Details
20.10.2. Company
Overview
20.10.3. Product
Offerings
20.10.4. Key
Developments
20.10.5. Financial
Analysis
20.10.6. SWOT
Analysis
20.10.7. Business
Strategies
20.11. Janssen
Pharmaceutica NV
20.11.1. Company
Details
20.11.2. Company
Overview
20.11.3. Product
Offerings
20.11.4. Key
Developments
20.11.5. Financial
Analysis
20.11.6. SWOT
Analysis
20.11.7. Business
Strategies
20.12. QIAGEN
20.12.1. Company
Details
20.12.2. Company
Overview
20.12.3. Product
Offerings
20.12.4. Key
Developments
20.12.5. Financial
Analysis
20.12.6. SWOT
Analysis
20.12.7. Business
Strategies
21. Key Findings
Note: This ToC is tentative and can be changed
according to the research study conducted
during
the course of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.